Moderna Inc (MRNA)

138.50
0.00(0.00%)
  • Volume:
    0
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    138.50 - 138.50

MRNA Overview

Prev. Close
168
Day's Range
138.5-138.5
Revenue
19.26B
Open
138.5
52 wk Range
120.35-210
EPS
21.22
Volume
0
Market Cap
56.71B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
16
P/E Ratio
6.89
Beta
1.7
1-Year Change
-13.63%
Shares Outstanding
385,677,955
Next Earnings Date
May 10, 2023
What is your sentiment on Moderna Inc?
or
Vote to see community's results!

Moderna Inc Company Profile

Moderna Inc Company Profile

  • Type:Equity
  • Market:Peru
  • ISIN:US60770K1079
  • S/N:MRNA

Moderna, Inc. is a biotechnology company that is focused on creating a transformative medicines based on messenger ribonucleic acid (mRNA), to improve the lives of patients. The Company’s mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range of spectrum of diseases. It is developing vaccines and therapeutics for infectious diseases, immuno-oncology, rare diseases, autoimmune and cardiovascular diseases, independently and with its strategic collaborators. The Company develops technologies that enable the development of mRNA medicines for diverse applications. It has created modalities, including prophylactic vaccines, systemic secreted and cell surface therapeutics, cancer vaccines, intratumoral immuno-oncology, and systemic intracellular therapeutics. The Company develops technologies that enable the development of mRNA medicines.

Read More

Technical Summary

Type
Daily
Weekly
Monthly
Moving AveragesStrong SellStrong SellSell
Technical IndicatorsStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong Sell